Results of a Phase II trial of tumor lysate-pulsed dendritic cell vaccination for malignant glioma

被引：1
|
作者：
Yu, JS
Black, KL
Liu, GT
Wheeler, CJ
Wagenberg, M
Das, A
Mindlin, E
Chu, RM
Luptrawan, A
Badruddoja, MA
机构：
来源：
NEUROSURGERY | 2005年 / 57卷 / 02期
关键词：
D O I：
10.1093/neurosurgery/57.2.409b
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
843
引用
收藏
页码：409 / 410
页数：2
相关论文
共 50 条
  • [21] Immunotherapy of Malignant Melanoma with Tumor Lysate-Pulsed Autologous Monocyte-Derived Dendritic Cells
    Kim, Dae Suk
    Kim, Dong Hyun
    Goo, Boncheol
    Cho, Young Hun
    Park, Jin Mo
    Lee, Tae Hyung
    Kim, Hyun Ok
    Kim, Han-Soo
    Lee, Hyunah
    Lee, Jong Doo
    Byamba, Dashlkhumbe
    Je, Jeong Hwan
    Lee, Min-Geol
    YONSEI MEDICAL JOURNAL, 2011, 52 (06) : 990 - 998
  • [22] Survivals in a Phase 1 trial of autologous tumor lysate-pulsed DC vaccination after resection of esophageal cancer
    Sato, Yasuyoshi
    Matsushita, Hirokazu
    Sugawara, Kotaro
    Yamashita, Hiroharu
    Mori, Kazuhiko
    Kakimi, Kazuhiro
    Seto, Yasuyuki
    ANNALS OF ONCOLOGY, 2017, 28
  • [23] A phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma
    Rudnick, J. D.
    Phuphanich, S.
    Chu, R.
    Mazer, M.
    Wang, H.
    Serrano, N.
    Francisco, M.
    Black, K. L.
    Wheeler, C.
    Yu, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma
    Kim, Jung Han
    Lee, Yoon
    Bae, Yong-Soo
    Kim, Won Seog
    Kim, Kihyun
    Im, Ho Yeong
    Kang, Won Ki
    Park, Keunchil
    Choi, Han Yong
    Lee, Hyun Moo
    Kang, Won Ki
    Lee, Hyunah
    Doh, Hyounmie
    Kim, Byong-Moon
    Kim, Chae Young
    Jeon, ChoonJu
    Jung, Chu Won
    CLINICAL IMMUNOLOGY, 2007, 125 (03) : 257 - 267
  • [25] Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells
    Höltl, L
    Zelle-Rieser, C
    Gander, H
    Papesh, C
    Ramoner, R
    Bartsch, G
    Rogatsch, H
    Barsoum, AL
    Coggin, JH
    Thurnher, M
    CLINICAL CANCER RESEARCH, 2002, 8 (11) : 3369 - 3376
  • [26] Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma
    Jiang, Xiao-bing
    Lu, Xiao-ling
    Hu, Peng
    Liu, Ru-en
    VACCINE, 2009, 27 (44) : 6210 - 6216
  • [27] TUMOUR LYSATE PULSED DENDRITIC CELL VACCINATION FOR CHILDREN WITH HIGH GRADE GLIOMA
    Wallace, Rebecca
    Flutter, Barry
    Morgenestern, Daniel
    Hargrave, Darren
    Blanco, Esther
    Howe, Karen
    Lowdell, Mark
    Samuel, Edward
    Michalski, Antony
    Anderson, John
    NEURO-ONCOLOGY, 2014, 16 : 59 - 59
  • [28] Induction of cellular immune response against autologous tumor cells by vaccination with autologous tumor lysate-pulsed dendritic cells
    Yasumoto, Kosei
    So, Tetsuya
    Nose, Naohiro
    Yoshimatsu, Takashi
    Tomiyama, Mai
    Maekawa, Ryuji
    LUNG CANCER, 2012, 77 : S27 - S27
  • [29] Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer
    Kao, JY
    Zhang, M
    Chen, CM
    Chen, JJ
    IMMUNOLOGY LETTERS, 2005, 101 (02) : 154 - 159
  • [30] Vaccination therapy of pancreatic carcinoma patients with autologous, tumor-lysate pulsed dendritic cells: Results of a phase II study
    Bauer, C.
    Dauer, M.
    Schnurr, M.
    Jauch, K.
    Ruettinger, D.
    Conrad, C.
    Bruns, C.
    Emmerich, B.
    Endres, S.
    Eigler, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345